We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.
Deadlines
 

UC CAI Technology Development Award, Pre-applications Due
Deadline: March 23, 2018 05:00 PM



This deadline has passed and is no longer active

UC CAI Request for Applications Now Available
Pre-applications submission period is March 19 - 23, 2018

Read the NHLBI RFA

UC CAI anticipates awarding multiple Technology Development Grants worth $200,000 each for development of drugs, devices (including wireless), diagnostics, and tools that address heart, lung and blood diseases. Most technologies will be awarded at $200,000, however, technologies that would substantially benefit from up to $400,000 may submit an application at both the $200,000 and $400,000 funding levels.

Faculty in all series and ranks at UC Davis, Irvine, Los Angeles, San Diego and San Francisco are eligible. Postdoctoral scholars are eligible to submit as Co-PI with a faculty PI.

Pre-applications are required and must be submitted between March 19 – 23, 2018.

NEW for 2018!! UC CAI is hosting a pitch day to provide an opportunity for two-way communication with CAI leadership and industry experts. Selected pre-applicants will pitch their technology to outside industry experts, providing an opportunity for exposure and real-time feedback. The pitch day will allow applicants to make business connections, write a more competitive proposal and inform CAI leadership as to the nature, utility and commercial potential of their invention.

UC CAI will invite innovators to participate in the pitch day on the basis of a pre-application. Full applicants will be invited following the pitch day.

About the UC CAI
The UC CAI is a collaboration of five UC medical campuses to accelerate the translation of UC discoveries to benefit patients with heart, lung and blood diseases. It is administered from UCLA and supported by the National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, and the CTSAs at UC Davis, Irvine, Los Angeles, San Diego and San Francisco. It is one of three such centers in the U.S.


Return to Deadline Listings